Corner Therapeutics is a biotechnology research company that specializes in the immunotherapy paradigm.
Corner Therapeutics has raised $54.0M in total funding. The most recent round was Series A. The last funding was announced in April 2024.
Corner Therapeutics's investors include Bill & Melinda Gates Foundation, Tanis ventures, Ziff Capital Partners, Cockrell Interests, Sandia Holdings.
Corner Therapeutics is headquartered in Watertown, United States.
Corner Therapeutics is a biotechnology research company that specializes in the immunotherapy paradigm.
Corner Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Corner Therapeutics — Funding & Investors." VCBacked, April 18, 2024, https://www.vcbacked.co/company/corner-therapeutics. Accessed July 31, 2026.
VCBacked. (2024). Corner Therapeutics — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/corner-therapeutics
{{cite web |title=Corner Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/corner-therapeutics |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated